Authors:
COHEN MA
HUBAND MD
YODER SL
GAGE JW
ROLAND GE
Citation: Ma. Cohen et al., BACTERIAL ERADICATION BY CLINAFLOXACIN, CI-990, AND CIPROFLOXACIN EMPLOYING MBC TEST, IN-VITRO TIME-KILL AND IN-VIVO TIME-KILL STUDIES, Journal of antimicrobial chemotherapy, 41(6), 1998, pp. 605-614
Authors:
COHEN MA
HUBAND MD
GAGE JW
YODER SL
ROLAND GE
GRACHECK SJ
Citation: Ma. Cohen et al., IN-VITRO ACTIVITY OF CLINAFLOXACIN, TROVAFLOXACIN, AND CIPROFLOXACIN, Journal of antimicrobial chemotherapy, 40(2), 1997, pp. 205-211
Citation: Ma. Cohen et al., SPARFLOXACIN WORLDWIDE IN-VITRO LITERATURE - ISOLATE DATA AVAILABLE THROUGH 1994, Diagnostic microbiology and infectious disease, 25(2), 1996, pp. 53-64
Authors:
COHEN MA
GAGE JW
HUBAND MD
MESERVEY MA
VANDERROEST SR
YODER SL
Citation: Ma. Cohen et al., EFFICACY OF QUINOLONES IN PREVENTING STAPHYLOCOCCUS AUREUS-INDUCED ABSCESS IN MICE, Journal of antimicrobial chemotherapy, 36(3), 1995, pp. 551-555
Authors:
COHEN MA
YODER SL
HUBAND MD
ROLAND GE
COURTNEY CL
Citation: Ma. Cohen et al., IN-VITRO AND IN-VIVO ACTIVITIES OF CLINAFLOXACIN, CI-990 (PD-131112),AND PD-138312 VERSUS ENTEROCOCCI, Antimicrobial agents and chemotherapy, 39(9), 1995, pp. 2123-2127
Authors:
COHEN MA
WOLD SA
MESERVEY MA
GAGE JW
HEIFETZ C
MAILLOUX GB
ROLAND GE
YODER SL
Citation: Ma. Cohen et al., IN-VIVO THERAPEUTIC EFFICACY OF CEFDINIR (FK482), A NEW ORAL CEPHALOSPORIN, AGAINST STAPHYLOCOCCUS-AUREUS AND HAEMOPHILUS-INFLUENZAE IN MOUSE INFECTION MODELS, Diagnostic microbiology and infectious disease, 18(1), 1994, pp. 41-47
Authors:
HUBAND MD
COHEN MA
MESERVEY MA
ROLAND GE
YODER SL
DAZER ME
DOMAGALA JM
Citation: Md. Huband et al., IN-VITRO ANTIBACTERIAL ACTIVITIES OF PD 138312 AND PD 140248, NEW FLUORONAPHTHYRIDINES WITH OUTSTANDING GRAM-POSITIVE POTENCY, Antimicrobial agents and chemotherapy, 37(12), 1993, pp. 2563-2570